You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

27 January 2022

Find information about the supply of COVID-19 rapid antigen self-tests to assist sponsors, manufacturers and consumers.

25 January 2022

A list of self-tests that are approved in Australia

17 January 2022
Updated guidance for businesses using rapid antigen tests approved by the TGA as point-of-care tests
17 January 2022

Find out about the different ways we test for COVID-19 in Australia.

14 January 2022
Important information about the use of COVID-19 point-of-care tests.
12 January 2022

Find information about advertising COVID-19 rapid tests.

12 January 2022

Find out information about the different types of tests and how the TGA assesses them and monitors their performance.

12 January 2022
Answers to frequently asked questions in relation to rapid antigen tests.
11 January 2022

Find information about advertising COVID-19 rapid tests.

21 December 2021

The TGA is undertaking a post-market review of all Point of Care and Laboratory tests included in the ARTG, which are intended to identify patients with COVID-19, to ensure they can detect the emerging SARS-CoV-2 genetic variants and remain accurate.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us